KYTX
NASDAQ
US
Kyverna Therapeutics, Inc. - Common Stock
$8.87
▲ +$0.10
(+1.14%)
Vol 757K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$537.0M
ROE
-77.9%
D/E
0.13
Beta
1.61
52W
$2–$14
Wall Street Consensus
12 analysts · Apr 20264
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating
Price Chart
Similar Stocks
MDXG
MiMedx Group Inc
P/E 24.6
$1.0B
IRWD
Ironwood Pharmaceuticals Inc
P/E 19.2
$548.2M
PROK
Prokidney Corp
$673.9M
TECX
Tectonic Therapeutic Inc
$390.4M
EIKN
Eikon Therapeutics Inc
CBIO
Crescent Biopharma Inc
$164.8M
ZURA
Zura Bio Ltd
$340.7M
UPB
Upstream Bio Inc
$1.5B
RIGL
Rigel Pharmaceuticals Inc
P/E 6.9
$777.4M
LRMR
Larimar Therapeutics Inc
$326.1M
Earnings
Beat rate: 80.0%
Next Report
May 11, 2026
EPS Estimate: $-0.77
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.77 | — | — |
| Dec 2025 | $-0.88 | $-0.80 | +$0.08 |
| Sep 2025 | $-0.99 | $-0.85 | +$0.14 |
| Jun 2025 | $-1.06 | $-0.97 | +$0.09 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -64.9% | -64.9% | -64.9% | -64.9% | -77.9% | -77.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.17 | 0.17 | 0.17 | 0.17 | 0.13 | 0.13 |
| Current Ratio | 5.39 | 5.39 | 5.39 | 5.39 | 5.16 | 5.16 |
Key Ratios
ROA (TTM)
-65.8%
P/B
0.6
EPS (TTM)
$-3.72
52W High
$13.67
52W Low
$1.78
$1.78
52-Week Range
$13.67
How does KYTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
KYTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.6
▼
75%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
KYTX profitability vs Biotechnology peers
ROE
-77.9%
▼
16%
below
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-65.8%
▼
41%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
KYTX financial health vs Biotechnology peers
D/E ratio
0.1
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
5.2
▲
16%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
1.6
▲
66%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
KYTX fundamentals radar
KYTX
Peer median
Industry
KYTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
KYTX vs peers: key metrics
Latest News
No related news yet